Search Results 91-100 of 16287 for monoclonal antibody

  1. Multiple sclerosis - Diagnosis and treatment - Mayo Clinic

    This treatment is a monoclonal antibody that decreases annual relapse rates and demonstrates MRI benefits. This drug helps reduce relapses of MS by ...

  2. Rituximab-Abbs (Intravenous Route) Description and Brand Names - Mayo Clinic

    Rituximab-abbs is a monoclonal antibody. Rituximab-abbs injection is used together with other cancer medicines (eg, fludarabine and cyclophosphamide) to ...

  3. OCEAN (depemOkimab effiCacy Eosinophilic grAnulomatosis with polyaNgiitis) - Mayo Clinic

    Depemokimab is a humanised, affinity matured monoclonal antibody that blocks human interleukin-5 (IL-5) binding to its receptor. Depemokimab is being ...

  4. Ipilimumab (Intravenous Route) Description and Brand Names - Mayo Clinic

    It is a monoclonal antibody that changes the immune system to help control the growth of cancer cells in the skin. Ipilimumab injection is also used to help ...

  5. Pertuzumab (Intravenous Route) Description and Brand Names - Mayo Clinic

    The HER2 protein is produced by some breast tumors. Pertuzumab is a monoclonal antibody that interferes with the growth of this protein, which is eventually ...

  6. Neuromyelitis optica: New therapies offer hope - Mayo Clinic

    The newly approved treatments are three monoclonal antibodies: ... Rituximab, a monoclonal antibody often used to treat NMOSD , costs about $18,000 a year.

  7. Infliximab-axxq (intravenous route) - Mayo Clinic

    Infliximab-axxq is a monoclonal antibody that works to enhance and improve the immune system. This medicine is to be given only by or under the direct ...

  8. Clinical trials - Oncology (Medical)

    Rituximab is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. ... Immunotherapy with monoclonal antibodies, such as ...

  9. Publications - Caroline G. Clune, M.D. - Mayo Clinic

    ... Monoclonal Antibody Screening Score. Mayo Clin Proc Innov Qual Outcomes. 2023 Apr; 7 (2):109-121 Epub 2023 Jan 11. View PubMed; Fraker JL, Clune CG, Sahni SK ...

  10. A Study to Evaluate Maximizing Anti-PD-1 Therapy By Monitoring T Cell Responses In Melanoma, Lung and Other Cancer Types - Mayo Clinic

    ... monoclonal antibody, and compare them with clinical outcomes. Participation eligibility. Participant eligibility includes age, gender, type and stage of ...